Get the Stockscreener App
59.33
0.83%
0.49
After Hours:
59.44
0.11
+0.19%
Revolution Medicines Inc stock is traded at $59.33, with a volume of 2.54M.
It is up +0.83% in the last 24 hours and up +27.02% over the past month.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.
See More
Previous Close:
$58.84
Open:
$58.93
24h Volume:
2.54M
Relative Volume:
1.22
Market Cap:
$11.09B
Revenue:
$29.52M
Net Income/Loss:
$-567.06M
P/E Ratio:
-16.21
EPS:
-3.66
Net Cash Flow:
$-551.11M
1W Performance:
+2.31%
1M Performance:
+27.02%
6M Performance:
+45.70%
1Y Performance:
+7.70%
1-Day Range:
$56.66
$59.44
1-Week Range:
$56.66
$60.08
52-Week Range:
$29.17
$62.40
Revolution Medicines Inc Stock (RVMD) Company Profile
Name
Revolution Medicines Inc
Sector
Industry
Phone
415-766-3638
Address
700 SAGINAW DR, REDWOOD CITY, CA
Compare RVMD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RVMD
Revolution Medicines Inc
|
59.33 | 11.00B | 29.52M | -567.06M | -551.11M | -3.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Revolution Medicines Inc Stock (RVMD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-21-25 | Initiated | Mizuho | Outperform |
| Oct-16-25 | Resumed | Stifel | Buy |
| Sep-12-25 | Resumed | Raymond James | Strong Buy |
| Sep-05-25 | Initiated | Truist | Buy |
| Aug-19-25 | Initiated | Piper Sandler | Overweight |
| Aug-15-25 | Initiated | Wells Fargo | Overweight |
| Jul-15-25 | Initiated | Goldman | Buy |
| Jul-16-24 | Reiterated | Needham | Buy |
| Jul-12-24 | Initiated | Barclays | Overweight |
| Jul-08-24 | Initiated | Jefferies | Buy |
| Apr-12-24 | Reiterated | Needham | Buy |
| Apr-10-24 | Upgrade | Raymond James | Outperform → Strong Buy |
| Mar-11-24 | Initiated | Piper Sandler | Overweight |
| Jan-05-24 | Upgrade | BofA Securities | Neutral → Buy |
| Jan-04-24 | Initiated | Wedbush | Outperform |
| Nov-16-23 | Initiated | Raymond James | Outperform |
| Feb-28-23 | Upgrade | JP Morgan | Neutral → Overweight |
| Dec-14-22 | Initiated | Needham | Buy |
| Oct-21-22 | Initiated | Oppenheimer | Outperform |
| May-20-22 | Initiated | BofA Securities | Neutral |
| Mar-01-22 | Upgrade | Stifel | Hold → Buy |
| Sep-23-21 | Initiated | Stifel | Hold |
| Aug-12-21 | Downgrade | Goldman | Buy → Neutral |
| May-18-21 | Initiated | Goldman | Buy |
| May-21-20 | Initiated | H.C. Wainwright | Buy |
| Mar-09-20 | Initiated | Cowen | Outperform |
| Mar-09-20 | Initiated | Guggenheim | Buy |
| Mar-09-20 | Initiated | JP Morgan | Neutral |
View All
Revolution Medicines Inc Stock (RVMD) Latest News
Revolution Medicines (RVMD) Receives Outperform Rating from RBC Capital - GuruFocus
Revolution Medicines a new outperform at RBC on RAS(ON) inhibitors for cancers - MSN
Revolution Medicines is Best-Positioned to Execute Targeting RAS-Mutated Cancers, RBC Says - MarketScreener
RBC Capital Initiates Coverage on RVMD with an 'Outperform' Rati - GuruFocus
What high frequency data says about Revolution Medicines Inc.2025 Earnings Impact & High Accuracy Investment Signals - newser.com
What MACD and RSI say about Revolution Medicines Inc. Equity Warrant2025 AllTime Highs & Low Risk Growth Stock Ideas - newser.com
Why Revolution Medicines Inc. Equity Warrant stock remains a top recommendation2025 Support & Resistance & Consistent Profit Alerts - newser.com
Applying sector rotation models to Revolution Medicines Inc. Equity WarrantJuly 2025 Review & Daily Chart Pattern Signals - newser.com
Is Revolution Medicines Inc. Equity Warrant showing signs of accumulationMarket Trend Review & Free Reliable Trade Execution Plans - newser.com
Should I hold or sell Revolution Medicines Inc. Equity Warrant stock in 20252025 EndofYear Setup & Free Fast Gain Swing Trade Alerts - newser.com
RBC Initiates Revolution Medicines at Outperform, Speculative Risk With $77 Price Target - MarketScreener
How analysts rate Revolution Medicines Inc. stock today2025 Top Decliners & Reliable Entry Point Alerts - newser.com
Is Revolution Medicines Inc. a candidate for recovery playPortfolio Performance Report & Entry Point Confirmation Signals - newser.com
Revolution Medicines Inc. stock trend outlook and recovery pathJuly 2025 Volume & Real-Time Stock Price Movement Reports - newser.com
Technical signs of recovery in Revolution Medicines Inc.2025 Breakouts & Breakdowns & Safe Investment Capital Preservation Plans - newser.com
Real time scanner hits for Revolution Medicines Inc. explained2025 Investor Takeaways & Weekly Consistent Profit Watchlists - newser.com
Technical signs of recovery in Revolution Medicines Inc. Equity WarrantTrade Analysis Report & Low Drawdown Investment Strategies - newser.com
Visual analytics tools that track Revolution Medicines Inc. Equity Warrant performancePortfolio Update Report & Stepwise Entry/Exit Trade Alerts - newser.com
What institutional flow reveals about Revolution Medicines Inc. Equity WarrantMarket Movement Recap & Stepwise Trade Signal Implementation - newser.com
Is Revolution Medicines Inc. stock a bargain at current levels2025 Key Lessons & High Accuracy Investment Signals - newser.com
How Revolution Medicines Inc. stock performs in rising dollar environmentTrade Ideas & Verified Stock Trade Ideas - newser.com
How Revolution Medicines Inc. (42Z) stock reacts to weak economyMarket Risk Analysis & Reliable Price Action Trade Plans - newser.com
Why Revolution Medicines Inc. (42Z) stock is a strong analyst pickWeekly Trend Report & Smart Swing Trading Alerts - newser.com
Published on: 2025-11-02 21:21:19 - newser.com
Using Bollinger Bands to evaluate Revolution Medicines Inc. Equity WarrantQuarterly Trade Summary & Low Drawdown Trading Strategies - newser.com
What makes Revolution Medicines Inc. (42Z) stock appealing to growth investors2025 Market Outlook & Daily Stock Trend Watchlist - newser.com
What to expect from Revolution Medicines Inc. Equity Warrant in the next 30 days2025 Year in Review & Low Drawdown Momentum Ideas - newser.com
Is Revolution Medicines Inc. Equity Warrant stock a buy on dipsEarnings Growth Summary & Low Drawdown Investment Ideas - newser.com
Revolution Medicines Inc. Equity Warrant stock retracement – recovery analysisJuly 2025 Macro Moves & Smart Allocation Stock Reports - newser.com
Published on: 2025-11-02 01:57:56 - newser.com
Revolution Medicines, Inc. (RVMD) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Developing predictive dashboards with Revolution Medicines Inc. Equity Warrant dataWatch List & Safe Entry Point Identification - newser.com
Why Revolution Medicines Inc. stock is in analyst buy zoneJuly 2025 Breakouts & Free Reliable Trade Execution Plans - newser.com
Detecting price anomalies in Revolution Medicines Inc. with AIJuly 2025 Fed Impact & Weekly High Return Stock Forecasts - newser.com
Is a relief rally coming for Revolution Medicines Inc. holdersMarket Movement Recap & Fast Entry Momentum Alerts - newser.com
Measuring Revolution Medicines Inc. Equity Warrant’s beta against major indicesEarnings Performance Report & Free Low Drawdown Momentum Trade Ideas - newser.com
Revolution Medicines Inc Stock (RVMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.64%
0.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):